Research map: Efficacy and Safety of Alpha-Lipoic Acid as an Adjunctive Therapy in Schizophrenia

Back to the article

Papers in this map

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews · Matthew James Page · 2021 · 106363 citations · Cited by this paper
  2. Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies · 2026 · Related
  3. RoB 2: a revised tool for assessing risk of bias in randomised trials · Jonathan A C Sterne · 2019 · 33351 citations · Cited by this paper
  4. Journal of Clinical Psychopharmacology Updates · 2026 · Related
  5. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions · Jonathan A C Sterne · 2016 · 20246 citations · Cited by this paper
  6. Vortioxetine Related Hypertriglyceridemia in a Young Male · 2026 · Related
  7. How to perform a meta-analysis with R: a practical tutorial · Sara Balduzzi · 2019 · 6001 citations · Cited by this paper
  8. Sugarless Candy in Treatment-Resistant Clozapine-Induced Sialorrhea · 2026 · Related
  9. THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES · W. George Cochran · 1950 · 1331 citations · Cited by this paper
  10. Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia · 2026 · Related
  11. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications · Felicity Ng · 2008 · 1078 citations · Cited by this paper
  12. Menorrhagia Associated With Extended-Release Methylphenidate in an Adult Woman · 2026 · Related
  13. Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid · Lester Packer · 1997 · 641 citations · Cited by this paper
  14. Hypnopompic Hallucinations · 2026 · Related
  15. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019 · Marco Solmi · 2023 · 583 citations · Cited by this paper
  16. Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us · 2026 · Related
  17. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia · Robin Alexander Emsley · 2014 · 73 citations · Cited by this paper
  18. Amantadine as an Alternative to VMAT2 Inhibitors for Tardive Dyskinesia in Patients at Risk of Depression and Suicidality · 2026 · Related
  19. Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials · Kah Kheng Goh · 2021 · 54 citations · Cited by this paper
  20. Escitalopram-Associated Myopericarditis in a Young Adult · 2026 · Related
  21. Adjunctive α-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics · Nam Wook Kim · 2016 · 33 citations · Cited by this paper
  22. Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs · Guillaume B. Fond · 2023 · 30 citations · Cited by this paper
  23. α-Lipoic Acid as Adjunctive Treatment for Schizophrenia · Lia Lira Olivier Sanders · 2017 · 28 citations · Cited by this paper
  24. Effects of Alpha-Lipoic Acid Supplementation on Plasma Adiponectin Levels and Some Metabolic Risk Factors in Patients with Schizophrenia · Bojana B. Vidović · 2016 · 27 citations · Cited by this paper
  25. An Open-Label Pilot Trial of Alpha-Lipoic Acid for Weight Loss in Patients with Schizophrenia without Diabetes · Joseph C. Ratliff · 2013 · 26 citations · Cited by this paper
  26. Pathological Implications of Oxidative Stress in Patients and Animal Models with Schizophrenia: The Role of Epidermal Growth Factor Receptor Signaling · Tadasato Nagano · 2015 · 21 citations · Cited by this paper
  27. Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis · Alessandro Miola · 2021 · 17 citations · Cited by this paper
  28. Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial · Archana Mishra · 2022 · 17 citations · Cited by this paper
  29. α-Lipoic Acid as Adjunctive Treatment for Schizophrenia · David Nunes de Lima · 2022 · 16 citations · Cited by this paper
  30. The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis · Xianrong Xu · 2022 · 15 citations · Cited by this paper
  31. Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” · Michele Fornaro · 2024 · 15 citations · Cited by this paper
  32. R-lipoic acid overdosing affects platelet life span via ROS mediated autophagy · Jing Liu · 2017 · 12 citations · Cited by this paper
  33. Metabolic and clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study · Fiammetta Iannuzzo · 2022 · 9 citations · Cited by this paper

Source: OpenAlex (CC0)